Navigation Links
Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H1, 2013
Date:12/5/2013

London (PRWEB) December 05, 2013

Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, “Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H1, 2013" provides data on the Venous Leg Ulcers (Crural ulcer) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Leg Ulcers (Crural ulcer). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous Leg Ulcers (Crural ulcer). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner
-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
-Obtain discontinued trial listing for trials across the globe
-Espy the commercial landscape
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Elsevier, SVS announce 2013 launch of Journal of Vascular Surgery: Venous and Lymphatic Disorders
2. What Men Should Know About Veins: Varicose Veins and Venous Disease are Real Medical Issues
3. UTHealth research: Low incidence of venous insufficiency in MS
4. Dr. Cindy Asbjornsen of the Vein Healthcare Center invited to participate in Sedona Days with other leading venous experts from around the world
5. 2 venous punctures not always needed for intravascular ultrasound-guided
6. CoolTouch® Issued New “Endovenous Laser Treatment” Patent
7. South Bay Vascular Center and Vein Institute Offers New Help, Hope for Patients Born with Arteriovenous Malformation
8. Vein Specialties Seeing Younger Clientele with Venous Disorders
9. Premier Vein Institute Launches New Health Campaign via Social Media to Educate Public about Advanced Stages of Venous Disease
10. Siragusa Vein and Vascular Launches Health Campaign on Advanced Stages of Venous Disease
11. Comprehensive Vein Treatment Center Launches Campaign on Venous Insufficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... ... was formed in 2008, the result of a merger of five of the ... working cooperatively, they could provide more cost-effective and higher quality care than they ...
(Date:8/31/2015)... Scotch Plains, NJ (PRWEB) , ... August 31, 2015 , ... NJ Top Docs Presents, ... Doc”!, Born and raised in Park Ridge, New Jersey, Dr. Michael Betsy graduated from Don ... and ice hockey and served as team captain in both sports in his senior year. ...
(Date:8/31/2015)... ... , ... Dr. Stewart Shofner of Shofner Vision Center explains what ... a comprehensive eye examination can diagnose amblyopia. According to the National Eye Institute ... approximately 2 to 3 out of every 100 children. , Dr. Shofner adds, ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... communications company announced today that it has officially launched a new website and ... website and brand refresh are more closely aligned with the company’s strategic vision ...
(Date:8/31/2015)... ... ... Three Bakers Gluten Free Bakery launched the redesign of its website, ... on their offering of gluten-free breads and pizzas, living without gluten, and resources for ... to share information about our gluten free product offerings, but also to really be ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2
... Locoid Lotion was recently introduced at the ... Chicago, Illinois, for the treatment of mild-to-moderate ... Triax Pharmaceuticals, LLC, the marketers of Locoid ... brand in corticosteroids, recently launched the new ...
... 12, 2008 (Portland, Ore.) People who lose weight ... control of their blood pressure and blood sugar, and are ... their weight, according to a Kaiser Permanente study published online ... , This is the first clinical study to ...
... to the Head of the Class, WASHINGTON, Aug. ... heading back to classrooms this month, and 8,million (16%) ... according to the Asthma and Allergy Foundation of America,s,(AAFA) ... Asthma and,Allergy Policies for Schools -- many schools are ...
... MEDRAD, INC., announced today,that the wireless version ... Food and Drug Administration (FDA) 510(k) clearance., ... Continuum Wireless MR Infusion System enables the clinician ... resonance (MR),procedure from both inside and outside the ...
... ETHEX Corporation Subsidiary ... of October 24, 2008 for Gestiva(TM), ST. LOUIS, Aug. 11 KV Pharmaceutical Company,(NYSE: KVa/KVb) ... Fiscal 2009 First Quarter Financial Highlights (Unaudited), USD in millions ... Change ...
... Celsius Holdings,Inc. (OTC Bulletin Board: CSUH.OB) reported net sales ... $1.0 million -- a substantial increase,as compared to $376,000 for ... reported a net loss of $916,000 (or $0.01 per basic ... This compares,with net loss of $726,000 (or $0.01 per basic ...
Cached Medicine News:Health News:Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1% 2Health News:Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1% 3Health News:Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1% 4Health News:Losing weight soon after type 2 diabetes diagnosis doubles positive outcomes 2Health News:Six States Named to National Asthma & Allergy Honor Roll 2Health News:Six States Named to National Asthma & Allergy Honor Roll 3Health News:MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System 2Health News:MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System 3Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 2Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 3Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 4Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 5Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 6Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 7Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 8Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 9Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 10Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 11Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 12Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 13Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 14Health News:Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166% 2Health News:Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166% 3Health News:Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166% 4Health News:Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166% 5
(Date:8/30/2015)... Massachusetts y LONDRES, August 30, 2015 /PRNewswire/ ... ofrece una visión holística de l ... todo el trayecto   ... hoy el debut europeo de IntelliSpace Cardiovascular , ... que ofrece sofisticadas herramientas para acceder, analizar y compartir ...
(Date:8/28/2015)... , Aug. 28, 2015  Delays in ... projects can slow down the decision-making process, resulting ... therefore, absolutely critical for biopharmaceutical companies to develop ... approval process for quicker and more meaningful insights. ... Best Practices, LLC, nearly three-quarters of benchmarked study ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Originally discovered by Welfide ... Pharmaceutical Industries, Ltd) as an inflammatory drug, pranoprofen ... Pharmaceutical Co., Ltd under the trade name of ...
Breaking Medicine Technology:Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Pranoprofen Market, 2010-2019 2
... NEW YORK, April 28, 2011 Reportlinker.com ... is available in its catalogue: ... Healthcare System and Drug Regulatory Overview: Cost-containment ... http://www.reportlinker.com/p0487111/Pharmaceutical-Key-Trends-2011---Healthcare-System-and-Drug-Regulatory-Overview-Cost-containment-and-regulatory-pressures-intensify.html ...
... 28, 2011 West Pharmaceutical Services, Inc. (NYSE: ... quarter of 2011.  Summary comparative results were as follows:($ millions, ... 295.4 , $ 274.7Gross Profit , 88.0 , 82.2Reported Operating ... 30.7 , 29.5Reported Diluted EPS , $ 0.56 , $ ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 3Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 4Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 5Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 6West Announces First Quarter 2011 Results 2West Announces First Quarter 2011 Results 3West Announces First Quarter 2011 Results 4West Announces First Quarter 2011 Results 5West Announces First Quarter 2011 Results 6West Announces First Quarter 2011 Results 7West Announces First Quarter 2011 Results 8West Announces First Quarter 2011 Results 9West Announces First Quarter 2011 Results 10West Announces First Quarter 2011 Results 11West Announces First Quarter 2011 Results 12West Announces First Quarter 2011 Results 13West Announces First Quarter 2011 Results 14
The Plasma Extractor is used to express blood components from collection containers. The spring-loaded front panel exerts pressure on the collection container causing the fluid to transfer until cont...
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
... only catheter of its kind, the ... collects real-time cardiac electrical information, translating ... With 64 electrodes, this unique tool ... than 3,000 points of electrical data ...
... The St. Jude Medical® Pacing System Analyzer ... solution for implantation testing, programming and interrogation ... as an easy-to-use accessory to the St. ... testing by obtaining measurements of intrinsic P- ...
Medicine Products: